Challenges of developing and conducting clinical trials in rare disorders.

about

Conducting non-commercial international clinical trials: the ICR-CTSU experience.How to address the challenges of evaluating treatment benefits-risks in rare diseases? A convergent mixed methods approach applied within a Merkel cell carcinoma phase 2 clinical trial.

P2860

Q42364730-DF953096-1424-488E-9EFE-B08D0B21EDCF Q55356919-F31624C7-31BD-4CDC-AE38-15196C6C1F75

P2860

Challenges of developing and conducting clinical trials in rare disorders.

Item

http://www.wikidata.org/entity/Q52542078

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Challenges of developing and conducting clinical trials in rare disorders.

@en

Challenges of developing and conducting clinical trials in rare disorders.

@nl

type

Item

label

Challenges of developing and conducting clinical trials in rare disorders.

@en

Challenges of developing and conducting clinical trials in rare disorders.

@nl

prefLabel

Challenges of developing and conducting clinical trials in rare disorders.

@en

Challenges of developing and conducting clinical trials in rare disorders.

@nl

P1476

Challenges of developing and conducting clinical trials in rare disorders.

@en

P2093

Jonathan C Goldsmith

http://www.w3.org/2001/XMLSchema#string

Lucas Kempf

http://www.w3.org/2001/XMLSchema#string

Robert Temple

http://www.w3.org/2001/XMLSchema#string

P2860

Genetics of Parkinson's disease

Mendelian Inheritance in Man and its online version, OMIM

Predicting motor decline and disability in Parkinson disease: a systematic review.

Using information technology and social networking for recruitment of research participants: experience from an exploratory study of pediatric Klinefelter syndrome.

Adaptive Randomization of Neratinib in Early Breast Cancer.

Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer.

Quantitative telemedicine ratings in Batten disease: implications for rare disease research

Meta-analysis of clinical trials as a scientific discipline. I: Control of bias and comparison with large co-operative trials.

Chromosomal deletion at 22q11.2 and Parkinson's disease.

P304

773-783

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/AJMG.A.38413

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

176

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28815894

http://www.w3.org/2001/XMLSchema#string

Challenges of developing and conducting clinical trials in rare disorders.

about

P2860

P2860

Challenges of developing and conducting clinical trials in rare disorders.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698